KRAS and lung adenocarcinoma: How to cite this article: Lohinai, Z. et al. KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS-mutation and bone metastasis.